On 2026-02-26, Revelation Biosciences, Inc. (REVB) announced earnings per share of $-1.65 for the fiscal quarter ending 2025-12-31, missing the average analyst estimate of $-1.41.
The next expected annoucement date for quarterly earnings is 2026-05-14, with an average estimated earnings per share of $-1.15 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-02-26 | 2025-12-31 | $-1.41 | $-1.65 |
| 2025-11-06 | 2025-09-30 | $-5.36 | $-7.08 |
| 2025-08-07 | 2025-06-30 | $-17.84 | $-28.04 |
| 2025-05-08 | 2025-03-31 | $-82.57 | $-25.32 |
| 2025-03-06 | 2024-12-31 | $-38.40 | $-59.77 |
| 2024-11-08 | 2024-09-30 | $-545.33 | $-161.30 |
| 2024-08-09 | 2024-06-30 | $-347.55 | $-295.71 |
| 2024-05-10 | 2024-03-31 | $-1034.98 | $-472.37 |
| 2024-03-22 | 2023-12-31 | $-2100.69 | $-1599.52 |
| 2023-11-09 | 2023-09-30 | $-1729.90 | $-2364.20 |
| 2023-08-11 | 2023-06-30 | $-1902.89 | $-1441.59 |
| 2023-05-22 | 2023-03-31 | $-3748.12 | $-2940.83 |
| 2023-03-30 | 2022-12-31 | $-10091.10 | $-10206.43 |
| 2022-11-10 | 2022-09-30 | $-18145.83 | $-12097.22 |
| 2022-08-15 | 2022-06-30 | $-28226.85 | $-24194.44 |
| 2022-05-16 | 2022-03-31 | $-28226.85 | $-94761.57 |